Pentamidine-induced diabetes mellitus. 1985

B Naafs

UI MeSH Term Description Entries
D007896 Leishmaniasis A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). Leishmania Infection,Infection, Leishmania,Infections, Leishmania,Leishmania Infections,Leishmaniases
D010419 Pentamidine Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. Pentamidine Isethionate,Diamidine,Lomidine,NebuPent,Pentacarinat,Pentam,Pentamidin,Pentamidine Mesylate
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000578 Amidines Derivatives of oxoacids RnE(

Related Publications

B Naafs
July 1993, Revista clinica espanola,
B Naafs
March 1968, East African medical journal,
B Naafs
January 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene,
B Naafs
June 1991, Australian and New Zealand journal of medicine,
B Naafs
January 1978, Journees annuelles de diabetologie de l'Hotel-Dieu,
B Naafs
October 1991, The American journal of medicine,
B Naafs
March 1989, The American journal of the medical sciences,
B Naafs
December 1990, Anales de medicina interna (Madrid, Spain : 1984),
B Naafs
November 1996, The Medical journal of Australia,
Copied contents to your clipboard!